Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus.
Fernanda Espinosa-BautistaDania CoronelVarna Ramos-RosilloLuis M Amezcua GuerraPublished in: Lupus (2022)
Luminex performs better than hs-ELISA as a quantification platform for IP-10 as it correlates with disease activity and identifies active arthritis in SLE.